Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03381599 · ClinicalTrials.gov registry record · Phase 1
Stem Cells After Peripheral Mobilization and Harvest
A Phase 1 study, sponsored by Andrews Research & Education Foundation.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT03381599 is a Phase 1 study that has completed, run by Andrews Research & Education Foundation. The registered enrollment target is 10 participants.
The verdict
NCT03381599, a Phase 1 study, has completed, sponsored by Andrews Research & Education Foundation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The proposed study is a controlled laboratory study where stem cell content of bone marrow aspirate will be compared prior to and following pharmaceutical mobilization. Participants who meet the inclusion/exclusion criteria will have a bone marrow sample taken from the iliac crest. The sample will be tested to determine stem cell content and for the presence of proteins which are of interest in orthopedic treatments. Thirty days following the baseline bone marrow collection, participants will receive a subcutaneous injection of Filgrastim daily for four serial days. On the fifth day, a peripheral blood sample will be taken and processed.
Interventions
- DRUG Filgrastim Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-03-28 |
| Est. Completion | 2019-09-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03381599
The ClinicalTrials.gov registry entry for NCT03381599 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Andrews Research & Education Foundation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Filgrastim Injection is the first listed.
NCT03381599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03381599 about?
NCT03381599 is a clinical study titled "Stem Cells After Peripheral Mobilization and Harvest". The proposed study is a controlled laboratory study where stem cell content of bone marrow aspirate will be compared prior to and following pharmaceutical mobilization. Participants who meet the inclusion/exclusion criteria will have a bone marrow sample taken from the iliac crest. The sample will b...
What is the current status of trial NCT03381599?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2018-03-28. Estimated completion is 2019-09-04.
What interventions are being tested in trial NCT03381599?
The interventions under investigation include: Filgrastim Injection (DRUG).
Who is sponsoring clinical trial NCT03381599?
This trial is sponsored by Andrews Research & Education Foundation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.